Red flag upgrade for Pfizer: FDA limits Xeljanz in colitis, slaps black box on label

26th July 2019 Uncategorised 0

For Pfizer’s blockbuster immunology drug Xeljanz, an FDA safety communication has now turned into a boxed warning. And forget the drug’s approval as a first-line ulcerative colitis treatment, at least for now.

More: Red flag upgrade for Pfizer: FDA limits Xeljanz in colitis, slaps black box on label
Source: fierce